|
|
|
Pharmaceutical Manufacturing and Packing Sourcer
|
|
Medical packaging must comply with an increasingly complex set of requirements imposed by both regulation and the demands of product managers. Often, ease of use requirements are either ignored or seen as being at odds with other, more critical requirements, such as the requirements for child resistant packaging. An ageing population has caused renewed interest in designing medical packaging that is more ‘elderlyfriendly’ and generally easier to use. Human performance research has contributed greatly to knowledge bases and has led to a better understanding of how to meet the medical packaging needs of older adults, but many gaps remain. A user-centred approach during the design and optimisation of packaging solutions can lead to an engineered result that meets packaging requirements and the needs of consumers (1).
Medical packaging that is too difficult to open is a common source of consumer dissatisfaction (2). The demand for ease of use in medical packaging is expected to increase as the population ages. Agerelated functional decline in strength, dexterity, and visual ability directly impacts packaging ease of use (3-5). With an ageing population comes an increase in the prevalence of arthritis, which is the number one cause of disability in the US (6). The need for easy to use packaging for medical products designed to treat arthritis is clear. Consumers seeking relief from the symptoms of arthritis should not have to suffer while accessing their medication. Additionally, arthritis is a common comorbidity with other chronic diseases such as diabetes and heart disease, suggesting a compelling reason for addressing ease of use issues in all medical packaging (7).
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
PCI Pharma Services Announces Organization Updates
Philadelphia, PA – May 20, 2019 – PCI Pharma Services, a leading
biopharmaceutical outsourcing services provider, is pleased to announce
the following management updates to help drive the company’s future
vision, strategy and growth.
More info >> |
|
 |
White Papers |
 |
|
Future-proofing serialization solutions: the importance of strong level 3 capabilities
Adents
The complexities surrounding product serialization for pharmaceutical and medical device companies are immense. While current serialization requirements are limited to marking the unit of sale with a unique data carrier, by 2023 the process will require a product to be traceable through the entirety of its journey - from the individual package through the carton/pallet to its final point of distribution. In the United States, the Healthcare Distribution Management Association (HDMA) is suggesting that pharmaceutical companies begin to support this level of serialization, called aggregation, now. Around the world – in Europe and Asia in particular – disparate track and trace practices are incrementally moving toward a global standard that will, undoubtedly, be more stringent than today’s differing benchmarks. How can companies manage this transformation with the greatest degree of success while also minimizing business disruption? The key to creating an optimal implementation strategy is to select a serialization solution that has strong capabilities at all levels of technology. It’s also important to choose a solution that enables multi-phase implementation
More info >> |
|
 |
Industry Events |
 |
PDA Europe Annual Meeting 2019
24 June 2019, Hilton Amsterdam
Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >> |
|
|
